LOS ANGELES, Aug. 5, 2026 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Capricor Therapeutics, Inc. (CAPR) have opportunity to lead the securities fraud class action lawsuit.

IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN CAPRICOR THERAPEUTICS, INC. (CAPR), CLICK HERE BEFORE SEPTEMBER 28, 2026 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE
ONGOING SECURITIES FRAUD LAWSUIT.

What Is The Lawsuit About?
The complaint filed in this class action alleges that between December 17, 2025 and July 26, 2026, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company's business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) that the Company adopted changes to the pre-specified statistical analysis plan used to analyze clinical data for Deramiocel; (2) that the FDA had not agreed to those changes before the Company resubmitted the Deramiocel BLA; (3) that, as a result, there was a significant risk that the FDA could conclude the clinical results did not provide substantial evidence of effectiveness of Deramiocel; (4) that, as a result of the foregoing, there was a substantial risk to regulatory approval of Deramiocel for the treatment of Duchenne muscular dystrophy; and (5) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Contact Us To Participate or Learn More:

If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us.
The Law Offices of Frank R. Cruz, 
Email us at: info@frankcruzlaw.com
Call us at: 310-914-5007
Visit our website at: www.frankcruzlaw.com
Follow us for updates on Twitter: twitter.com/FRC_LAW.

If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.

To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.  

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View original content to download multimedia:https://www.prnewswire.com/news-releases/capricor-therapeutics-inc-capr-shareholders-who-lost-money-have-opportunity-to-lead-securities-fraud-lawsuit-302843526.html

SOURCE The Law Offices of Frank R. Cruz, Los Angeles